Question

In clinical trials of the allergy medicine Clarinex (5 mg), it was reported that 50 out of 1655 individuals in the Clarinex group and 31 out of 1652 individuals in the placebo group experienced dry mouth as a side effect of their respective treatments.
(a) Is the proportion of individuals experiencing dry mouth greater for those taking Clarinex than for those taking a placebo at the α = 0.05 level of significance?
(b) Is the difference between the groups practically significant?


$1.99
Sales0
Views65
Comments0
  • CreatedApril 28, 2015
  • Files Included
Post your question
5000